Thermo Fisher Scientific and JW Therapeutics forge strategic CAR-T therapy partnership in China
Thermo Fisher Scientific has entered into a significant agreement with Chinese cell therapy leader JW Therapeutics, granting non-exclusive commercial access to its Gibco CTS Dynabeads ... Read More
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa Biotech, a California-based point-of-care molecular diagnostic company, ... Read More
Thermo Fisher Scientific acquires Henogen from Novasep for €725m to expand viral vector manufacturing capabilities
Thermo Fisher Scientific has completed the acquisition of Henogen, a viral vector manufacturing business previously owned by Groupe Novasep, for €725 million in cash. This ... Read More
Thermo Fisher opens manufacturing site for COVID-19 sample collection products
Thermo Fisher Scientific has officially inaugurated a new $40 million facility for manufacturing COVID-19 sample collection products in Lenexa, Kansas, which will exclusively produce viral ... Read More
Thermo Fisher scraps $11.5bn Qiagen deal after failed tender offer
Thermo Fisher Scientific has scrapped its previously planned $11.5 billion acquisition of Qiagen after its offer to buy all of the ordinary shares of the ... Read More
Thermo Fisher, WuXi, Mayo Clinic to develop total antibodies Covid-19 test
US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo Clinic to develop a total antibodies Covid-19 ... Read More
Thermo Fisher to acquire Qiagen to expand specialty diagnostics portfolio
Thermo Fisher acquisition of Qiagen : US life sciences company Thermo Fisher Scientific has agreed to acquire Qiagen, a Netherlands-based provider of molecular diagnostics and ... Read More
Thermo Fisher coronavirus diagnostic test gets FDA’s emergency use order
Thermo Fisher Scientific has been granted an emergency use authorization (EUA) for its coronavirus diagnostic test from the US Food and Drug Administration (FDA). The ... Read More
Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about $1.7 billion in cash. Brammer ... Read More
Thermo Fisher Scientific acquires rapid DNA technology provider IntegenX
Thermo Fisher Scientific, a Massachusetts-based biotech product development company has acquired California-based IntegenX, which offers a rapid DNA technology for human identification for forensic and ... Read More